NSC |
Compound |
Enrichment |
Correlation |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0295480456086947 |
0.19398574 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0295480456086947 |
0.093127268 |
NSC 13484 |
Null |
0.0295480456086947 |
0.24632535 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0295480456086947 |
0.050743462 |
NSC 287069 |
Epicorazine A |
0.0295480456086947 |
0.10062603 |
NSC 319947 |
2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- |
0.0295480456086947 |
0.36392704 |
NSC 618857 |
4-Piperidinone, 3,5-bis[[(4-methylthio)phenyl]methylene]-, hydrochloride |
0.0303322639291194 |
0.2146877 |
NSC 621486 |
2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- |
0.0303322639291194 |
-0.07288539 |
NSC 627371 |
2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- |
0.0303322639291194 |
0.013768602 |
NSC 639505 |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.0303322639291194 |
0.23157706 |